BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Markmann AJ, Giallourou N, Bhowmik DR, Hou YJ, Lerner A, Martinez DR, Premkumar L, Root H, van Duin D, Napravnik S, Graham SD, Guerra Q, Raut R, Petropoulos CJ, Wrin T, Cornaby C, Schmitz J, Kuruc J, Weiss S, Park Y, Baric R, de Silva AM, Margolis DM, Bartelt LA. Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals. mSphere 2021;6:e0027521. [PMID: 34431693 DOI: 10.1128/mSphere.00275-21] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Bartelt LA, Markmann AJ, Nelson B, Keys J, Root H, Henderson HI, Kuruc J, Baker C, Bhowmik DR, Hou YJ, Premkumar L, Cornaby C, Schmitz JL, Weiss S, Park Y, Baric R, de Silva AM, Lachiewicz A, Napravnik S, van Duin D, Margolis DM. Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study. mBio 2022;:e0175122. [PMID: 36135380 DOI: 10.1128/mbio.01751-22] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Omran EA, Habashy RE, Ezz Elarab LA, Hashish MH, El-barrawy MA, Abdelwahab IA, Fekry MM. Anti-Spike and Neutralizing Antibodies after Two Doses of COVID-19 Sinopharm/BIBP Vaccine. Vaccines 2022;10:1340. [DOI: 10.3390/vaccines10081340] [Reference Citation Analysis]
3 Shim HW, Shin JH, Shin SC, Lee HJ, So KS, Lee SY, Jun JW, Seo JK, Lee HS, Lee SY, Kim SH, Kim SJ, Kim K, Ryu GH. Analysis of Factors Affecting Neutralizing Antibody Production after COVID-19 Vaccination Using Newly Developed Rapid Point-of-Care Test. Diagnostics 2022;12:1924. [DOI: 10.3390/diagnostics12081924] [Reference Citation Analysis]
4 Kim Y, Bae JY, Kwon K, Chang HH, Lee WK, Park H, Kim J, Choi I, Park MS, Kim SW. Kinetics of neutralizing antibodies against SARS-CoV-2 infection according to sex, age, and disease severity. Sci Rep 2022;12:13491. [PMID: 35931794 DOI: 10.1038/s41598-022-17605-1] [Reference Citation Analysis]
5 Schuh AJ, Satheshkumar PS, Dietz S, Bull-Otterson L, Charles M, Edens C, Jones JM, Bajema KL, Clarke KEN, McDonald LC, Patel S, Cuffe K, Thornburg NJ, Schiffer J, Chun K, Bastidas M, Fernando M, Petropoulos CJ, Wrin T, Cai S, Adcock D, Sesok-Pizzini D, Letovsky S, Fry AM, Hall AJ, Gundlapalli AV. SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection. Microbiol Spectr 2022;:e0124722. [PMID: 35856710 DOI: 10.1128/spectrum.01247-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Vega-magaña N, Muñoz-valle JF, Peña-rodríguez M, Viera-segura O, Pereira-suárez AL, Hernández-bello J, García-chagollan M. Specific T-Cell Immune Response to SARS-CoV-2 Spike Protein over Time in Naïve and SARS-CoV-2 Previously Infected Subjects Vaccinated with BTN162b2. Vaccines 2022;10:1117. [DOI: 10.3390/vaccines10071117] [Reference Citation Analysis]
7 Schmidt AE, Vogel P, Chastain CA, Barnes T, Roth NJ, Simon TL. Analysis of 52 240 source plasma donors of convalescent COVID-19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation. J Clin Apher 2022. [PMID: 35815776 DOI: 10.1002/jca.21998] [Reference Citation Analysis]
8 Nguyen DC, Lamothe PA, Woodruff MC, Saini AS, Faliti CE, Sanz I, Lee FE. COVID-19 and plasma cells: Is there long-lived protection? Immunol Rev 2022. [PMID: 35801537 DOI: 10.1111/imr.13115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Sherwani S, Khan MWA, Mallik A, Khan M, Saleem M, Raafat M, Shati AA, Alam N. Seroprevalence of Anti-S1-RBD Antibodies in Pre-pandemic and Pandemic Subjects From Hail Region, KSA. Front Public Health 2022;10:874741. [PMID: 35757607 DOI: 10.3389/fpubh.2022.874741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jacobsen H, Sitaras I, Jurgensmeyer M, Mulders MN, Goldblatt D, Feikin DR, Bar-Zeev N, Higdon MM, Knoll MD. Assessing the Reliability of SARS-CoV-2 Neutralization Studies That Use Post-Vaccination Sera. Vaccines (Basel) 2022;10:850. [PMID: 35746460 DOI: 10.3390/vaccines10060850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lopez CA, Cunningham CH, Pugh S, Brandt K, Vanna UP, Delacruz MJ, Guerra Q, Bhowmik DR, Goldstein SJ, Hou YJ, Gearhart M, Wiethorn C, Pope C, Amditis C, Pruitt K, Newberry-Dillon C, Schmitz JL, Premkumar L, Adimora AA, Baric RS, Emch M, Boyce RM, Aiello AE, Fosdick BK, Larremore DB, de Silva AM, Juliano JJ, Markmann AJ. Ethnoracial Disparities in SARS-CoV-2 Seroprevalence in a Large Cohort of Individuals in Central North Carolina from April to December 2020. mSphere 2022;:e0084121. [PMID: 35587682 DOI: 10.1128/msphere.00841-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bartelt LA, Markmann AJ, Nelson B, Keys J, Root H, Henderson HI, Kuruc J, Baker C, Bhowmik DR, Hou YJ, Premkumar L, Cornaby C, Schmitz JL, Weiss S, Park Y, Baric R, de Silva AM, Lachiewicz A, Napravnik S, van Duin D, Margolis DM. Outcomes of convalescent plasma with defined high- versus lower-neutralizing antibody titers against SARS-CoV-2 among hospitalized patients: CoronaVirus Inactivating Plasma (CoVIP), double-blind phase 2 study.. [DOI: 10.1101/2022.04.29.22274387] [Reference Citation Analysis]
13 Qaqish A, Abbas MM, Al-tamimi M, Abbas MA, Al-omari M, Alqassieh R. SARS-CoV-2 Antinucleocapsid Antibody Response of mRNA and Inactivated Virus Vaccines Compared to Unvaccinated Individuals. Vaccines 2022;10:643. [DOI: 10.3390/vaccines10050643] [Reference Citation Analysis]
14 Trabace L, Pace L, Morgese MG, Santo IB, Galante D, Schiavone S, Cipolletta D, Rosa AM, Reveglia P, Parisi A, Tucci P, Pepe G, Sacco R, Foschino Barbaro MP, Corso G, Fasanella A. SARS-CoV-2 Gamma and Delta Variants of Concern Might Undermine Neutralizing Activity Generated in Response to BNT162b2 mRNA Vaccination. Viruses 2022;14:814. [PMID: 35458544 DOI: 10.3390/v14040814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Arnold CG, Libby A, Vest A, Hopkinson A, Monte AA. Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes. Biol Sex Differ 2022;13:7. [PMID: 35246245 DOI: 10.1186/s13293-022-00417-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
16 Rosati M, Terpos E, Ntanasis-Stathopoulos I, Agarwal M, Bear J, Burns R, Hu X, Korompoki E, Donohue D, Venzon DJ, Dimopoulos MA, Pavlakis GN, Felber BK. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection. Front Immunol 2021;12:793953. [PMID: 34899762 DOI: 10.3389/fimmu.2021.793953] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
17 Cimolai N. Passive Immunity Should and Will Work for COVID-19 for Some Patients. Clin Hematol Int 2021;3:47-68. [PMID: 34595467 DOI: 10.2991/chi.k.210328.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Cerami C, Rapp T, Lin FC, Tompkins K, Basham C, Muller MS, Whittelsey M, Zhang H, Chhetri SB, Smith J, Litel C, Lin K, Churiwal M, Khan S, Claman F, Rubinstein R, Mollan K, Wohl D, Premkumar L, Juliano JJ, Lin JT. High household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color. medRxiv 2021:2021. [PMID: 33758871 DOI: 10.1101/2021.03.10.21253173] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 19.0] [Reference Citation Analysis]
19 González F, Vielot NA, Sciaudone M, Toval-ruíz C, Premkumar L, Gutierrez L, Cuadra EC, Munguia N, Blandón P, de Silva AM, Rubinstein R, Bowman N, Becker-dreps S, Bucardo F. Seroepidemiology of SARS-CoV-2 infections in an urban population-based cohort in León, Nicaragua. Epidemiol Infect 2021;149:e247. [DOI: 10.1017/s0950268821002144] [Reference Citation Analysis]